Barclays’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$93.5M Buy
1,196,051
+7,638
+0.6% +$597K 0.02% 375
2025
Q1
$86.1M Sell
1,188,413
-5,372
-0.4% -$389K 0.02% 364
2024
Q4
$88.4M Sell
1,193,785
-389,164
-25% -$28.8M 0.02% 327
2024
Q3
$104M Buy
1,582,949
+488,837
+45% +$32.3M 0.03% 342
2024
Q2
$101M Sell
1,094,112
-222,400
-17% -$20.5M 0.03% 321
2024
Q1
$126M Buy
1,316,512
+18,523
+1% +$1.77M 0.04% 291
2023
Q4
$99M Buy
1,297,989
+179,398
+16% +$13.7M 0.04% 328
2023
Q3
$77.5M Sell
1,118,591
-81,462
-7% -$5.64M 0.05% 354
2023
Q2
$113M Buy
1,200,053
+693,374
+137% +$65.4M 0.07% 240
2023
Q1
$41.9M Sell
506,679
-419,061
-45% -$34.7M 0.02% 383
2022
Q4
$69.1M Buy
925,740
+122,365
+15% +$9.13M 0.03% 267
2022
Q3
$66.4M Buy
803,375
+145,855
+22% +$12.1M 0.07% 237
2022
Q2
$62.5M Sell
657,520
-368,352
-36% -$35M 0.04% 261
2022
Q1
$121M Sell
1,025,872
-915,514
-47% -$108M 0.09% 199
2021
Q4
$252M Buy
1,941,386
+560,331
+41% +$72.6M 0.09% 138
2021
Q3
$156M Buy
1,381,055
+436,022
+46% +$49.4M 0.07% 173
2021
Q2
$97.9M Buy
945,033
+216,339
+30% +$22.4M 0.05% 231
2021
Q1
$60.9M Sell
728,694
-119,674
-14% -$10M 0.03% 295
2020
Q4
$77.4M Buy
848,368
+33,927
+4% +$3.1M 0.04% 211
2020
Q3
$65M Buy
814,441
+312,313
+62% +$24.9M 0.04% 225
2020
Q2
$34.7M Sell
502,128
-393,738
-44% -$27.2M 0.03% 306
2020
Q1
$56.3M Sell
895,866
-132,873
-13% -$8.35M 0.04% 183
2019
Q4
$80M Sell
1,028,739
-468,924
-31% -$36.5M 0.04% 232
2019
Q3
$110M Sell
1,497,663
-930,081
-38% -$68.2M 0.07% 157
2019
Q2
$149M Buy
2,427,744
+868,389
+56% +$53.5M 0.09% 127
2019
Q1
$99.5M Buy
1,559,355
+251,517
+19% +$16M 0.07% 159
2018
Q4
$66.8M Buy
1,307,838
+375,987
+40% +$19.2M 0.05% 193
2018
Q3
$54.1M Buy
931,851
+257,001
+38% +$14.9M 0.04% 258
2018
Q2
$32.7M Sell
674,850
-238,665
-26% -$11.6M 0.03% 349
2018
Q1
$42.5M Buy
913,515
+26,304
+3% +$1.22M 0.03% 343
2017
Q4
$33.3M Buy
887,211
+478,662
+117% +$18M 0.03% 353
2017
Q3
$14.9M Buy
408,549
+96,549
+31% +$3.52M 0.02% 456
2017
Q2
$12.3M Sell
312,000
-130,980
-30% -$5.16M 0.01% 477
2017
Q1
$13.9M Buy
442,980
+155,409
+54% +$4.87M 0.02% 403
2016
Q4
$8.98M Buy
287,571
+175,266
+156% +$5.47M 0.01% 554
2016
Q3
$4.51M Sell
112,305
-284,634
-72% -$11.4M 0.01% 728
2016
Q2
$13.2M Buy
396,939
+155,901
+65% +$5.18M 0.02% 393
2016
Q1
$7.07M Sell
241,038
-199,326
-45% -$5.85M 0.01% 544
2015
Q4
$11.4M Buy
440,364
+64,830
+17% +$1.69M 0.01% 426
2015
Q3
$8.89M Buy
375,534
+74,526
+25% +$1.76M 0.01% 512
2015
Q2
$7.12M Sell
301,008
-660,420
-69% -$15.6M 0.01% 678
2015
Q1
$22.8M Buy
961,428
+553,368
+136% +$13.1M 0.03% 376
2014
Q4
$8.64M Buy
408,060
+62,088
+18% +$1.31M 0.01% 702
2014
Q3
$5.88M Sell
345,972
-351,558
-50% -$5.97M 0.01% 880
2014
Q2
$9.88M Buy
697,530
+155,736
+29% +$2.21M 0.01% 647
2014
Q1
$6.68M Buy
541,794
+6,774
+1% +$83.6K 0.01% 854
2013
Q4
$5.8M Sell
535,020
-19,050
-3% -$206K 0.01% 938
2013
Q3
$6.37M Sell
554,070
-216,660
-28% -$2.49M 0.01% 788
2013
Q2
$8.63M Buy
+770,730
New +$8.63M 0.01% 626